A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder
Open Access
- 15 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Addiction Science & Clinical Practice
- Vol. 16 (1), 1-11
- https://doi.org/10.1186/s13722-021-00245-7
Abstract
Objective: Most Americans with opioid use disorder (OUD) do not receive indicated medical care. A clinical decision support (CDS) tool for primary care providers (PCPs) could address this treatment gap. Our primary objective was to build OUD-CDS tool and demonstrate its functionality and accuracy. Secondary objectives were to achieve high use and approval rates and improve PCP confidence in diagnosing and treating OUD. Methods: A convenience sample of 55 PCPs participated. Buprenorphine-waivered PCPs (n = 8) were assigned to the intervention. Non-waivered PCPs (n = 47) were randomized to intervention (n = 24) or control (n = 23). Intervention PCPs received access to the OUD-CDS, which alerted them to patients at potentially increased risk for OUD or overdose and guided diagnosis and treatment. Control PCPs provided care as usual. Results: The OUD-CDS was functional and accurate following extensive multi-phased testing. PCPs used the OUD-CDS in 5% of encounters with at-risk patients, far less than the goal of 60%. OUD screening confidence increased for all intervention PCPs and OUD diagnosis increased for non-waivered intervention PCPs. Most PCPs (65%) would recommend the OUD-CDS and found it helpful with screening for OUD and discussing and prescribing OUD medications. Discussion: PCPs generally liked the OUD-CDS, but use rates were low, suggesting the need to modify CDS design, implementation strategies and integration with existing primary care workflows. Conclusion: The OUD-CDS tool was functional and accurate, but PCP use rates were low. Despite low use, the OUD-CDS improved confidence in OUD screening, diagnosis and use of buprenorphine. NIH Trial registration NCT03559179. Date of registration: 06/18/2018. URL: https://clinicaltrials.gov/ct2/show/NCT03559179Keywords
Funding Information
- National Institute on Drug Abuse (3UG1DA040316)
This publication has 27 references indexed in Scilit:
- The Impact of Electronic Patient Portals on Patient Care: A Systematic Review of Controlled TrialsJournal of Medical Internet Research, 2012
- Impact of a computerized system for evidence-based diabetes care on completeness of records: a before–after studyBMC Medical Informatics and Decision Making, 2012
- Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary CareJournal of General Internal Medicine, 2012
- A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and ProbationersSubstance Abuse, 2012
- Collaborative Care of Opioid-Addicted Patients in Primary Care Using BuprenorphineJAMA Internal Medicine, 2011
- Factors affecting willingness to provide buprenorphine treatmentJournal of Substance Abuse Treatment, 2009
- Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative StudyJournal of General Internal Medicine, 2008
- Office-Based Management of Opioid Dependence with Buprenorphine: Clinical Practices and BarriersJournal of General Internal Medicine, 2008
- Grand challenges in clinical decision supportJournal of Biomedical Informatics, 2007
- Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent PatientsJournal of General Internal Medicine, 2007